Last reviewed · How we verify
Compound Vitamin B12 — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Compound Vitamin B12 (Compound Vitamin B12) — Wei LUO.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Compound Vitamin B12 TARGET | Compound Vitamin B12 | Wei LUO | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Compound Vitamin B12 CI watch — RSS
- Compound Vitamin B12 CI watch — Atom
- Compound Vitamin B12 CI watch — JSON
- Compound Vitamin B12 alone — RSS
Cite this brief
Drug Landscape (2026). Compound Vitamin B12 — Competitive Intelligence Brief. https://druglandscape.com/ci/compound-vitamin-b12. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab